Skip to content

The value of ultrasound-guided percutaneous lung biopsy in the diagnosis of subpleural pulmonary lesions: a prospective, multicenter study

The value of ultrasound-guided percutaneous lung biopsy in the diagnosis of subpleural pulmonary lesions: a prospective, multicenter study

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100045374
Enrollment
Unknown
Registered
2021-04-13
Start date
2021-04-15
Completion date
Unknown
Last updated
2021-11-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subpleural Pulmonary Lesions

Interventions

B-mode ultrasound group:
CT group:
B-mode ultrasound+Contrast-Enhanced Ultrasound group (B-US + CEUS):

Sponsors

Shanghai Pulmonary Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1.Patients whose pulmonary lesions were located beneath the pleura by X-ray, CT or US and were to be biopsied by percutaneous lung biopsy; 2.The target lesions can be clearly displayed in US, CEUS and CT images, which can meet the indications of percutaneous biopsy guided by these three imaging methods; 3.The subjects agreed to participate in this study and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Severe cardiovascular disease; 2. Patients allergic to ultrasound contrast agents; 3. Patients with uncontrollable infection at the site to be punctured or the whole body; 4. Patients with severe coagulopathy; 5. Those who suffer from severe Alzheimer's disease or other mental illnesses that interfere with operation and result evaluation; 6. Pregnant women, under 18 years old and other special groups; 7. The investigator believes that it is inappropriate to participate in or continue to participate in the clinical trial patients.

Design outcomes

Primary

MeasureTime frame
Diagnostic accuracy;

Secondary

MeasureTime frame
Success rate of sampling;False negative rate;Operating time;Puncture times;Adverse event rate;

Countries

China

Contacts

Public ContactWang Yin

Shanghai Pulmonary Hospital

lpbbl@aliyun.com+86 13701885138

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026